XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2022
Stock-Based Compensation  
Stock-Based Compensation

(8)  Stock-Based Compensation

A summary of stock option activity for the nine months ended September 30, 2022 is as follows:

Weighted

Weighted

Average

Average

Exercise

Remaining

Price

Contractual

    

Shares

    

Per Share

    

Term (In Years)

Options outstanding at December 31, 2021

 

4,077,667

$

30.02

8.0

Granted

 

1,584,900

$

22.89

Exercised

 

(353,622)

$

6.71

Canceled

 

(118,974)

$

50.12

Options outstanding at September 30, 2022

 

5,189,971

$

28.97

8.07

Options vested and expected to vest at September 30, 2022

 

5,031,072

$

29.21

8.05

Options exercisable at September 30, 2022

 

1,985,506

$

41.56

6.74

Shares available for grant under the 2021 Plan

 

1,838,291

The weighted average grant-date fair value of stock options granted during the three and nine months ended September 30, 2022 was $25.38 and $17.36, respectively.

The aggregate intrinsic value of stock options vested and expected to vest at September 30, 2022 was $45.6 million. The aggregate intrinsic value of stock options exercisable at September 30, 2022 was $23.6 million. As of September 30, 2022, total compensation cost related to non-vested employee, consultant and non-employee director stock options not yet recognized was approximately $46.7 million, net of estimated forfeitures, which is expected to be recognized as expense over a weighted average period of 2.8 years.

Stock-based compensation expense for the three and nine months ended September 30, 2022 and 2021 was recorded as follows:

Three months ended September 30, 

Nine months ended September 30, 

    

2022

    

2021

    

2022

    

2021

(In thousands)

(In thousands)

Research and development

$

2,342

$

1,504

$

5,754

$

2,927

General and administrative

 

2,154

 

1,525

 

5,349

 

2,886

Total stock-based compensation expense

$

4,496

$

3,029

$

11,103

$

5,813

The fair values of employee, consultant and non-employee director stock options granted during the three and nine months ended September 30, 2022 and 2021 were valued using the Black-Scholes option pricing model with the following assumptions:

Three months ended September 30, 

Nine months ended September 30, 

    

    

2022

    

2021

    

2022

    

2021

Expected stock price volatility

 

91%

98%

90 – 97%

97 – 98%

Expected option term

 

6.0 Years

6.0 Years

6.0 Years

6.0 Years

Risk-free interest rate

 

2.9 – 3.5%

1.1 – 1.2%

1.7 – 3.6%

0.8 – 1.3%

Expected dividend yield

 

None

None

None

None